The U.S. Patent and Trademark Office issued a notice of allowance to Milestone Scientific for the company's patent application, Computer Controlled Drug Delivery System with Dynamic Pressure Sensing.
Dynamic pressure sensing provides visual and audible in-tissue pressure feedback, identifying tissue types to the healthcare provider, according to the company. This feedback allows a healthcare provider to know when certain types of tissue have been penetrated, allowing for the injection of medicaments at a precise location. This is particularly beneficial when making subcutaneous and intramuscular injections, Milestone noted.
"This notice of allowance is of profound significance to our company, in that the noted intellectual property represents one of the key technological components that will afford Milestone Scientific the opportunity to enter the medical drug delivery market," said Mark Hochman, director of clinical affairs, in a press release. "Intra-articular, epidurals, along with numerous other injections should undergo a revolutionary change in the areas of efficacy, safety, and cost benefits."
A notice of allowance generally completes the substantive examination of a patent application.
Copyright © 2009 DrBicuspid.com
%20nov12024.q9h8imREpF.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
%20nov12024.q9h8imREpF.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
